Clinical Trial: Study of MCLA-129 in the Treatment of Advanced Non-small Cell Lung Cancer with AGA and MET Amplification.

U.S., March 21 -- ClinicalTrials.gov registry received information related to the study (NCT06885840) titled 'Study of MCLA-129 in the Treatment of Advanced Non-small Cell Lung Cancer with AGA and MET Amplification.' on March 14.

Brief Summary: This is a multi-center, open-label, phase II clinical study of MCLA-129 as monotherapy in patients with advanced non-small cell lung cancer (NSCLC) with actionable gene alterations and MET amplification to evaluate the efficacy, safety, pharmacokinetic characteristics of MCLA-129.

Study Start Date: March 31

Study Type: INTERVENTIONAL

Condition: Non-Small Cell Lung Cancer

Intervention: DRUG: MCLA-129

MCLA-129 will be administered by intravenous infusion on the 28-day treatment cycle.

Recruitm...